// App-Quantinova.ai

OA39 : Development of a Childhood Lupus Low Disease Activity State definition: recommendations from the International Childhood Lupus Treat-to-Target Task Force

Researchers

Presenter

  • Eve M D Smith

Principal Investigators

  • Jenny Ainsworth

  • Eslam Al-Abadi

  • Tadej Avcin

  • Lynette Bortey

  • Jon Burnham

  • Coziana Ciurtin

  • Christian M Hedrich

  • Sylvia Kamphuis

  • Deborah Levy

  • Laura Lewandowski

  • Naomi Maxwell

  • Eric Morand

  • Seza Ozen

  • Clare Pain

  • Angelo Ravelli

  • Claudia Saad Magalhaes

  • Clarissa Pilkington

  • Dieneke Schonenberg

  • Chris Scott

  • Kjell Tullus

  • Michael W Beresford

Medical Centers

  • Department of Pediatric Rheumatology and Clinical Immunology, University Medical Center Ljubljana, Ljubljana, Slovenia

  • Department of Paediatric Rheumatology, Birmingham Women’s and Children’s Hospital NHS Foundation Trust, Birmingham, United Kingdom

  • Dipartimento Neuroscienze, Riabilitazione, Oftalmologia, Genetica e Scienze Materno-Infantili DiNOGMI, Universita degli Studi di Genova, Genova, Italy

  • Department of Endocrinology, Alder Hey Childrens NHS Foundation Trust, Liverpool, United Kingdom

  • Department of Women’s & Children’s Health, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom

  • Direzione Scientifica, IRCCS Istituto Giannina Gaslini, Genoa, Italy

  • Department of Immunology, Monash University, Melbourne, Australia

  • Department of Pathology, The Children's Hospital of Philadelphia, Philadelphia, PA

  • Department of Pediatric Oncology, Hacettepe University, Ankara, Turkey

  • TARGET Lupus Public Patient Involvement and Engagement Group, of Women’s & Children’s Health, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom

  • Paediatric Rheumatology, University of Cape Town, Cape Town, South Africa

  • Department of Pediatric Rheumatology, Botucatu Medical School, Sao Paulo State University, Sao Paulo, Brazil

  • Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Post Graduate Institute of Medical Science, Lucknow, Uttar Pradesh, India

  • Department of Pediatric Anesthesiology, Great Ormond Street Hospital,NHS, London, United Kingdom

  • Department of Pediatric Immunology, Rheumatology and Infectious diseases, Emma Children's Hospital, Amsterdam, Netherlands

  • Paediatric Haematology, Great Ormond Street Hospital, London, United Kingdom

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD

  • Department of Pathology, Erasmus MC University Medical Center ENSAT, Rotterdam, Netherlands

  • Department of Pediatrics, The Hospital for Sick Children and the University of Toronto, Toronto, ON, Canada

  • Centre for Adolescent Rheumatology Versus Arthritis, Department of Medicine, University College London, London

Locations

  • Slovenia

  • United Kingdom

  • South Africa

  • Italy

  • Brazil

  • India

  • Netherlands

  • Australia

  • United States

  • Turkey

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final